Bydureon combined with Metformin Hcl

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Injection Site Abscess Hospitalization 1/6/2012 Male 2/6/2012 Consumer Germany
Primary
Concomitant
Dizziness Other Serious 12/1/2011 62 Female 2/10/2012 Consumer Germany
Primary
Concomitant
Off Label Use Hospitalization 1/6/2012 47 Male 2/1/2012 Other Health Professional Germany
Primary
Concomitant
Arrhythmia Hospitalization 1/23/2012 63 Female 2/13/2012 Consumer Germany
Primary
Concomitant
Chest Pain Hospitalization 12/15/2011 Male 2/14/2012 Consumer Germany
Primary
Concomitant
Lipase Increased Hospitalization 11/17/2011 51 Male 2/16/2012 Consumer Germany
Primary
Concomitant
Blood Glucose Increased Hospitalization 12/22/2011 Female 2/17/2012 Consumer Germany
Primary
Concomitant
Abdominal Pain Upper Other Serious 12/15/2011 63 Female 2/8/2012 Other Health Professional Germany
Primary
Secondary
Concomitant
Biliary Colic Hospitalization 1/25/2012 53 Female 2/27/2012 Consumer Germany
Primary
Concomitant
Visual Acuity Reduced Other Serious 2/1/2012 Male 2/29/2012 Consumer Germany
Primary
Concomitant
Urticaria Other Serious 11/2/2011 45 Female 265 lb 3/12/2012 Consumer United Kingdom
Primary
Concomitant
Abdominal Discomfort Hospitalization 12/1/2011 Female 3/13/2012 Consumer Germany
Primary
Concomitant
Ischaemic Cardiomyopathy Hospitalization 63 Female 3/14/2012 Physician Germany
Primary
Concomitant
Urinary Tract Infection Death 49 Female 3/22/2012 Consumer United Kingdom
Primary
Concomitant
Feeling Hot Other Serious 3/7/2012 52 Female 168 lb 3/26/2012 Consumer United States
Primary
Concomitant
Heart Rate Increased Other Serious 3/16/2012 67 Female 3/28/2012 Consumer Germany
Primary
Concomitant
Lipase Increased Other Serious 3/22/2012 Female 3/29/2012 Consumer Germany
Primary
Concomitant
Injection Site Erythema Other Serious 3/7/2012 52 Female 168 lb 4/3/2012 Consumer United States
Primary
Concomitant
Rectal Cancer Stage Ii Hospitalization 1/1/2012 Male 302 lb 4/3/2012 Physician Germany
Primary
Concomitant
Rash Generalised Other Serious 3/11/2012 66 Male 220 lb 4/3/2012 Physician Germany
Primary
Concomitant
Off Label Use Life Threatening 3/11/2012 66 Male 220 lb 4/10/2012 Physician Germany
Primary
Concomitant
Pancreatitis Chronic Other Serious 2/7/2012 65 Female 4/20/2012 Consumer Germany
Primary
Concomitant
Pruritus Generalised Other Serious Female 4/20/2012 Physician United States
Primary
Concomitant
Blood Glucose Increased Hospitalization 60 Male 213 lb 4/20/2012 Physician Germany
Primary
Concomitant
Angioedema Life Threatening 11/23/2011 Male 276 lb 4/24/2012 Consumer Germany
Primary
Concomitant
Urinary Tract Infection Death Female 386 lb 4/26/2012 Consumer United Kingdom
Primary
Concomitant
Left Ventricular Failure Hospitalization 63 Female 4/26/2012 Consumer Germany
Primary
Concomitant
Injection Site Nodule Hospitalization 2/15/2012 79 Male 175 lb 4/25/2012 Consumer United States
Primary
Concomitant
Malaise Other Serious Male 216 lb 4/30/2012 Physician United Kingdom
Primary
Concomitant
Injection Site Rash Other Serious 4/10/2012 62 Male 5/3/2012 Consumer United States
Primary
Concomitant
Neck Pain Other Serious 4/30/2012 34 Female 5/3/2012 Physician United States
Primary
Secondary
Concomitant
Abscess Oral Other Serious 37 Female 5/3/2012 Consumer United States
Primary
Concomitant
Pancreatitis Chronic Hospitalization 2/7/2012 65 Female 5/9/2012 Consumer Germany
Primary
Concomitant
Injection Site Nodule Other Serious 4/1/2012 42 Female 5/10/2012 Physician United States
Primary
Concomitant
Acarodermatitis Other Serious 11/2/2011 45 Female 265 lb 5/10/2012 Physician United Kingdom
Primary
Concomitant
Injection Site Reaction Other Serious 3/23/2012 64 Male 224 lb 5/14/2012 Physician United Kingdom
Primary
Concomitant
Dysphonia 5/9/2012 50 Female 177 lb 5/10/2012 Other Health Professional United States
Primary
Concomitant
Diarrhoea Other Serious 5/10/2012 46 Female 5/17/2012 Consumer United States
Primary
Concomitant
Angioedema Life Threatening 11/23/2011 Male 276 lb 5/18/2012 Consumer Germany
Primary
Concomitant
Panic Disorder Other Serious 4/1/2012 67 Female 5/18/2012 Consumer United States
Primary
Secondary
Concomitant
Swollen Tongue Other Serious 4/18/2012 60 Female 247 lb 5/21/2012 Physician United Kingdom
Primary
Concomitant
Salivary Gland Resection Other Serious 4/1/2012 66 Female 5/22/2012 Physician Germany
Primary
Concomitant
Injection Site Nodule Other Serious Female 5/23/2012 Physician United States
Primary
Concomitant
Lip Swelling Other Serious 5/14/2012 62 Female 177 lb 5/23/2012 Physician United States
Primary
Concomitant
Injection Site Mass Other Serious 4/1/2012 51 Female 262 lb 5/23/2012 Consumer United States
Primary
Concomitant
Injection Site Nodule Other Serious 4/23/2012 42 Female 165 lb 5/23/2012 Consumer United States
Primary
Concomitant
Vomiting Hospitalization 4/9/2012 Female 5/25/2012 Physician Germany
Primary
Concomitant
Biliary Colic Hospitalization 1/25/2012 53 Female 5/29/2012 Consumer Germany
Primary
Concomitant
Off Label Use Other Serious 4/20/2012 62 Female 182 lb 5/25/2012 Consumer United States
Primary
Concomitant
Blood Pressure Increased Other Serious 3/16/2012 67 Female 5/30/2012 Consumer Germany
Primary
Concomitant
Injection Site Rash Other Serious 4/1/2012 42 Female 6/7/2012 Physician United States
Primary
Concomitant
Gingival Infection Other Serious 5/1/2012 Male 6/11/2012 Consumer Germany
Primary
Concomitant
Blood Pressure Decreased Hospitalization 5/8/2012 Male 6/13/2012 Consumer Germany
Primary
Concomitant
Gastrointestinal Infection Other Serious 3/16/2012 67 Female 6/14/2012 Physician Germany
Primary
Concomitant
Angioedema Other Serious 5/14/2012 62 Female 177 lb 6/21/2012 Physician United States
Primary
Concomitant
Swelling Face Other Serious 4/28/2012 58 Female 232 lb 6/25/2012 Consumer United States
Primary
Secondary
Concomitant
Injection Site Nodule Other Serious 4/23/2012 42 Female 165 lb 6/27/2012 Consumer United States
Primary
Concomitant
Dizziness Other Serious 5/18/2012 41 Female 249 lb 6/27/2012 Physician United States
Primary
Concomitant
Carotid Artery Stenosis Other Serious 12/1/2011 Male 7/3/2012 Consumer Germany
Primary
Concomitant
Respiratory Tract Infection Viral Other Serious 6/1/2012 58 Female 215 lb 7/5/2012 Consumer United States
Primary
Secondary
Concomitant
Muscle Spasms Other Serious Female 230 lb 7/3/2012 Consumer United States
Primary
Concomitant
Pancreatic Neoplasm Other Serious 6/26/2012 63 Female 222 lb 7/5/2012 Physician United States
Primary
Concomitant
Blood Glucose Increased Other Serious 6/26/2012 60 Female 310 lb 7/10/2012 Consumer United States
Primary
Concomitant
Hypoaesthesia Oral Hospitalization 5/18/2012 41 Female 249 lb 7/11/2012 Physician United States
Primary
Concomitant
Blood Glucose Increased Other Serious 6/25/2012 60 Female 310 lb 7/19/2012 Consumer United States
Primary
Concomitant
Injection Site Inflammation Hospitalization 7/15/2012 Male 8/13/2012 Consumer Germany
Primary
Concomitant
Nephrolithiasis Other Serious 3/19/2012 56 Male 8/20/2012 Consumer Germany
Primary
Secondary
Concomitant
Hydrocholecystis Hospitalization 5/21/2012 61 Female 194 lb 8/24/2012 Physician Denmark
Primary
Concomitant
Weight Decreased Other Serious 2013 57 Female 225 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Pruritus Other Serious 52 Female 6/6/2013 Consumer Gb
Primary
Secondary
Haematemesis Hospitalization 1/22/2013 71 Female 8/16/2013 Consumer Us
Primary
Secondary
Concomitant
Pancreatitis Hospitalization 3/27/2013 61 Female 4/17/2013 Consumer Us
Primary
Secondary
Concomitant
Troponin Increased Hospitalization 65 Male 194 lb 5/3/2013 Consumer Gb
Primary
Secondary
Concomitant
Weight Decreased Other Serious Female 290 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Blood Glucose Increased 3/11/2013 69 Female 5/25/2013 Consumer Us
Primary
Concomitant
Blood Glucose Increased Male 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Blood Glucose Increased Male 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased 1/2013 72 Female 175 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased 2010 71 Male 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Wrong Technique In Drug Usage Process 47 Female 340 lb 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Pruritus 51 Male 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Haemorrhage 3/24/2013 52 Male 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Mass 60 Male 5/25/2013 Consumer Us
Primary
Concomitant
Underdose 3/14/2013 58 Male 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Mass 2/2013 61 Female 140 lb 5/25/2013 Consumer Us
Primary
Concomitant
Nausea 3/24/2013 39 Male 250 lb 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Nodule 67 Female 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use 2/23/2013 45 Male 11/26/2013 Consumer Us
Primary
Concomitant
Weight Decreased 3/16/2013 68 Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Oropharyngeal Pain 2/2013 55 Female 5/25/2013 Consumer Us
Primary
Concomitant
Blood Glucose Increased 3/13/2013 72 Female 5/25/2013 Consumer Us
Primary
Concomitant
Underdose 3/10/2013 63 Female 175 lb 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use Other Serious 71 Male 5/25/2013 Consumer Us
Primary
Concomitant
Underdose 62 Female 200 lb 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Pruritus 63 Male 5/25/2013 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious 12/24/2012 68 Female 189 lb 5/27/2013 Physician Us
Primary
Concomitant
Stress 61 Female 5/25/2013 Consumer Us
Primary
Concomitant
Urticaria Other Serious 3/15/2013 47 Female 180 lb 5/25/2013 Consumer Us
Primary
Concomitant
Weight Decreased Hospitalization 3/2008 51 Male 240 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Cerebrovascular Accident Hospitalization 71 Female 180 lb 5/31/2013 Consumer Us
Primary
Concomitant
Injection Site Nodule Other Serious 66 Female 165 lb 6/5/2013 Consumer Us
Primary
Secondary
Concomitant
Renal Failure Acute Hospitalization 4/1/2013 57 Male 207 lb 7/4/2013 Consumer Ro
Primary
Secondary
Concomitant
Weight Decreased Other Serious 2012 69 Male 225 lb 6/20/2013 Consumer Us
Primary
Secondary
Injection Site Pruritus 59 Female 193 lb 7/5/2013 Consumer Us
Primary
Secondary
Concomitant
Syncope Other Serious 69 Male 218 lb 11/26/2013 Physician Us
Primary
Secondary
Weight Decreased Hospitalization 3/15/2013 54 Female 209 lb 9/3/2013 Consumer In
Primary
Secondary
Concomitant
Weight Decreased Other Serious 64 Male 7/30/2013 Consumer Gb
Primary
Secondary
Nausea 65 Female 8/29/2013 Consumer Us
Primary
Secondary
Pancreatitis Other Serious 2013 77 Male 236 lb 9/20/2013 Physician Us
Primary
Secondary
Concomitant
Injection Site Pruritus 70 Male 175 lb 9/27/2013 Consumer Us
Primary
Secondary
Weight Decreased Hospitalization 2013 49 Male 303 lb 9/30/2013 Consumer Us
Primary
Secondary
Therapeutic Response Decreased Other Serious 57 Female 187 lb 10/18/2013 Consumer Us
Primary
Secondary
Concomitant
Fall Other Serious 2013 60 Male 10/30/2013 Consumer Se
Primary
Secondary
Weight Decreased 61 Female 177 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Pain 2013 65 Female 175 lb 11/26/2013 Consumer Us
Primary
Secondary
Vomiting 6/2013 48 Female 280 lb 11/26/2013 Consumer Us
Primary
Concomitant
Fatigue 70 Female 229 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Blood Glucose Increased 69 Male 11/26/2013 Consumer Us
Primary
Secondary
Drug Dose Omission 8/2013 59 Female 240 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Increased 2013 76 Male 230 lb 11/26/2013 Consumer Us
Primary
Concomitant
Diarrhoea 45 Female 366 lb 11/26/2013 Consumer Us
Primary
Secondary
Injection Site Nodule 54 Female 194 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Pain Male 11/26/2013 Other Health Professional Us
Primary
Secondary
Nausea 6/2013 56 Female 180 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Diarrhoea 5/2013 42 Male 300 lb 11/26/2013 Consumer Us
Primary
Secondary
Injection Site Swelling 8/2012 72 Female 187 lb 11/26/2013 Consumer Us
Primary
Secondary
Blood Glucose Increased 64 Male 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Pain 4/2013 75 Female 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Blood Glucose Increased 2013 61 Male 202 lb 11/26/2013 Consumer Us
Primary
Secondary
Wrong Technique In Drug Usage Process 58 Male 11/26/2013 Consumer Us
Primary
Secondary
Injection Site Pain 6/30/2013 47 Female 168 lb 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Pain 2013 63 Male 11/26/2013 Consumer Us
Primary
Secondary
Injection Site Nodule 2013 66 Female 11/26/2013 Consumer Us
Primary
Concomitant
Gastrointestinal Disorder 3/2013 Male 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Pain 46 Female 11/26/2013 Consumer Us
Primary
Secondary
Influenza 2/2013 49 Female 185 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Diarrhoea Hospitalization 1/2013 76 Male 260 lb 11/26/2013 Consumer Us
Primary
Secondary
Injection Site Reaction 1/2013 61 Female 175 lb 11/26/2013 Consumer Us
Primary
Secondary
Lymphoma Other Serious 2010 81 Female 148 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Reaction 65 Female 224 lb 11/26/2013 Consumer Us
Primary
Concomitant
Weight Decreased 64 Female 180 lb 11/26/2013 Consumer Us
Primary
Secondary
Injection Site Haemorrhage 2013 56 Male 220 lb 11/26/2013 Consumer Us
Primary
Concomitant
Malaise 2013 53 Male 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased 2013 64 Male 237 lb 11/26/2013 Consumer Us
Primary
Secondary
Blood Glucose Increased 7/1/2013 68 Male 11/26/2013 Consumer Us
Primary
Secondary
Injection Site Extravasation 39 Female 11/26/2013 Consumer Us
Primary
Secondary
Skin Disorder 58 Male 190 lb 11/26/2013 Consumer Us
Primary
Concomitant
Weight Decreased 3/2013 72 Male 11/26/2013 Consumer Us
Primary
Secondary
Injection Site Nodule 58 Female 195 lb 11/26/2013 Consumer Us
Primary
Secondary
Medication Error 70 Male 280 lb 11/26/2013 Consumer Us
Primary
Secondary

Drug Data